HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Just For Men's Hair-Dye Marketing Amounts To Civil Rights Violation – Plaintiff

This article was originally published in The Rose Sheet

Executive Summary

The latest class action targeting Just For Men owner Combe is a variation on a theme prevalent in other suits across the country, alleging that the company has failed to warn consumers adequately about p-phenylenediamine risks. This one goes further, asserting violations of federal equal rights law.

You may also be interested in...

Clairol Hair-Dye Suit Cites PPD Use, ‘Inadequate’ Home Sensitization Test

Current and former owners Coty and P&G knew or should have known about product hazards associated with Clairol Balsam Color hair-dye kits that are not adequately communicated to consumers, including the sensitizing potential of p-phenylenediamine, according to a putative class action filed in Alabama district court.

L’Oreal Hair-Relaxer Class Action A Far Cry From WEN, Or Next Plaintiff Payout?

Putative class actions against L’Oreal alleging that a Soft Sheen-Carson hair relaxer causes hair loss and scalp irritation have been consolidated in New York’s Southern District. Similar to complaints targeting WEN in recent years, the L’Oreal suits cite “an inherent design and/or manufacturing defect,” but L’Oreal says it provides ample warning of risks on product packaging and the category represents known hazards.

ECHA Supporting Efforts To Speed Disinfectants To European Market

The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to consumers and healthcare professionals fighting the novel coronavirus. Meanwhile, the ECHA encourages companies to work with national authorities on single-market applications for derogations under the Biocidal Products Regulation to speed up production.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts